Exhibit 99

NEWS RELEASE
SILICON LABORATORIES REPORTS STRONG SECOND QUARTER PERFORMANCE
AUSTIN, Texas July 22, 2005 Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal ICs, today reported revenues of $107 million and fully diluted GAAP earnings of $0.28 per share.
Financial Results
I am very pleased with the strong financial performance during the quarter. We continue to run a very healthy, profitable business that is well positioned to strongly invest in R&D to drive long-term revenue growth, said Russ Brennan, chief financial officer of Silicon Laboratories.
GAAP operating income for the second quarter was $18 million dollars or 17 percent of revenue. Excluding a $0.6 million non-cash charge for amortization of deferred stock compensation and a one time CEO severance charge of $1.9 million dollars, adjusted operating income for the second quarter was $20.4 million dollars, representing 19 percent of revenue which exceeded expectations. The company ended the quarter with cash and short-term investments up approximately $27 million to $330 million. The reconciling charges are set forth in the reconciliation of GAAP to non-GAAP financial measures table included below.
Business Summary
During the quarter, the broad-based mixed-signal business represented slightly more than half of total revenue and continued to diversify as adoption in the ProSLIC, MCU and Networking product lines increased. The companys recently announced digital power products experienced a high level of design activity among the leading providers of switched mode power supplies.
The company also continued to see a high level of design activity and development tool demand for the MCU products, which posted revenue growth again in Q2. Both product lines are contributing to the companys expansion into highly fragmented, highly profitable mixed-signal markets.
Mobile handset revenues increased by four percent during the quarter as demand recovered among customers in southeast Asia. Aero® II, the industrys most integrated RF transceiver for handsets, represented almost 40 percent of new design wins. Design activity on the companys recently announced FM tuner in both handset and MP3 devices is expected to result in production shipments in the third quarter of this year, three months earlier than anticipated.
I am very excited by the revenue potential of our recently announced new products as well as those in our pipeline, said Nav Sooch, chairman and interim-chief executive officer. After a close review of all of our R&D projects, I am confident that we are investing in the right activities to accelerate our revenue growth, increase our customer, market and product diversity and further improve our profitability.
The company anticipates revenue of $100 to $103 million in the third quarter of 2005.
Conference Call Today
A conference call discussing the second quarter results will follow the release at 7 a.m. Eastern Time. An audio webcast will be available simultaneously on Silicon Laboratories website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 800-513-1173 (U.S.) or +1 402-344-6829 (international). These replays will be available through August 5, 2005.
About Silicon Laboratories Inc.
Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with decades of cumulative expertise in cutting-edge mixed-signal design.
The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories please visit www.silabs.com.
Cautionary Language
This press release contains forward-looking statements based on Silicon Laboratories current expectations. The words believe, estimate, expect, intend, anticipate, plan, project, will and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly, especially for mobile handset products; dependence on a limited number of products and customers; risks associated with shifting market demand from GSM/GPRS to EDGE and WCDMA; difficulties developing new products that achieve market acceptance; risks that Silicon Laboratories may not be able to manage strains associated with its growth; dependence on key personnel; difficulties managing our manufacturers and subcontractors; difficulties managing international activities; credit risks associated with our accounts receivable; geographic concentration of manufacturers, assemblers, test service providers and customers in the Pacific Rim that subjects Silicon Laboratories business and results of operations to risks of natural disasters, epidemics, war and political unrest; product development risks; inventory-related risks; intellectual property litigation risks; risks associated with acquisitions; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Note to editors: Silicon Laboratories, ProSLIC, Aero and the Silicon Laboratories logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
CONTACT: Silicon Laboratories Inc., Shannon Pleasant, 512/464-9254 investor.relations@silabs.com
Silicon Laboratories Inc.
Unaudited Condensed Consolidated Statements of Income
(in thousands, except per share data)
|
|
|
Three Months Ended |
|
Six Months Ended |
|
||||||||
|
|
|
July 2, |
|
July 3, |
|
July 2, |
|
July 3, |
|
||||
|
Revenues |
|
$ |
107,156 |
|
$ |
126,130 |
|
$ |
211,920 |
|
$ |
239,753 |
|
|
Cost of revenues |
|
48,566 |
|
57,544 |
|
97,116 |
|
109,410 |
|
||||
|
Gross profit |
|
58,590 |
|
68,586 |
|
114,804 |
|
130,343 |
|
||||
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||
|
Research and development |
|
20,895 |
|
17,867 |
|
39,862 |
|
36,009 |
|
||||
|
Selling, general and administrative |
|
19,137 |
|
16,650 |
|
35,858 |
|
31,854 |
|
||||
|
Amortization of deferred stock compensation |
|
649 |
|
1,163 |
|
1,402 |
|
2,400 |
|
||||
|
Operating expenses |
|
40,681 |
|
35,680 |
|
77,122 |
|
70,263 |
|
||||
|
Operating income |
|
17,909 |
|
32,906 |
|
37,682 |
|
60,080 |
|
||||
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
||||
|
Interest income |
|
1,992 |
|
591 |
|
3,404 |
|
1,070 |
|
||||
|
Interest expense |
|
(45 |
) |
(115 |
) |
(101 |
) |
(165 |
) |
||||
|
Other income (expense), net |
|
(178 |
) |
193 |
|
(193 |
) |
2,008 |
|
||||
|
Income before income taxes |
|
19,678 |
|
33,575 |
|
40,792 |
|
62,993 |
|
||||
|
Provision for income taxes |
|
4,064 |
|
10,769 |
|
7,805 |
|
20,272 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Net income |
|
$ |
15,614 |
|
$ |
22,806 |
|
$ |
32,987 |
|
$ |
42,721 |
|
|
Net income per share: |
|
|
|
|
|
|
|
|
|
||||
|
Basic |
|
$ |
0.29 |
|
$ |
0.44 |
|
$ |
0.62 |
|
$ |
0.84 |
|
|
Diluted |
|
$ |
0.28 |
|
$ |
0.41 |
|
$ |
0.60 |
|
$ |
0.77 |
|
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
||||
|
Basic |
|
53,149 |
|
51,328 |
|
52,807 |
|
51,161 |
|
||||
|
Diluted |
|
55,027 |
|
55,294 |
|
55,196 |
|
55,293 |
|
||||
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(in thousands, except per share data)
|
|
|
Three Months Ended |
|
||||
|
|
|
July 2, |
|
July 3, |
|
||
|
GAAP operating income |
|
$ |
17,909 |
|
$ |
32,906 |
|
|
|
|
|
|
|
|
||
|
Adjustments: |
|
|
|
|
|
||
|
CEO separation agreement charge |
|
1,858 |
|
|
|
||
|
Amortization of deferred stock compensation |
|
649 |
|
1,163 |
|
||
|
Adjusted operating income |
|
$ |
20,416 |
|
$ |
34,069 |
|
|
|
|
|
|
|
|
||
|
Adjusted operating income % |
|
19 |
% |
27 |
% |
||
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(in thousands, except per share data)
|
|
|
July 2, |
|
January 1, |
|
||
|
|
|
(Unaudited) |
|
|
|
||
|
ASSETS |
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
224,213 |
|
$ |
48,636 |
|
|
Short-term investments |
|
106,158 |
|
228,470 |
|
||
|
Accounts receivable, net of allowance for doubtful accounts of $1,464 at July 2, 2005 and $1,088 at January 1, 2005 |
|
59,814 |
|
46,272 |
|
||
|
Inventories |
|
28,407 |
|
38,405 |
|
||
|
Deferred income taxes |
|
10,131 |
|
9,878 |
|
||
|
Prepaid expenses and other |
|
4,432 |
|
5,244 |
|
||
|
Total current assets |
|
433,155 |
|
376,905 |
|
||
|
Property, equipment and software, net |
|
29,539 |
|
34,559 |
|
||
|
Goodwill |
|
65,989 |
|
46,766 |
|
||
|
Other intangible assets, net |
|
14,174 |
|
15,384 |
|
||
|
Other assets, net |
|
12,693 |
|
10,788 |
|
||
|
Total assets |
|
$ |
555,550 |
|
$ |
484,402 |
|
|
|
|
|
|
|
|
||
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
|
||
|
Accounts payable |
|
$ |
32,937 |
|
$ |
37,001 |
|
|
Accrued expenses |
|
13,302 |
|
11,913 |
|
||
|
Deferred income on shipments to distributors |
|
31,351 |
|
25,227 |
|
||
|
Income taxes payable |
|
13,909 |
|
8,207 |
|
||
|
Total current liabilities |
|
91,499 |
|
82,348 |
|
||
|
Long-term obligations and other liabilities |
|
1,849 |
|
2,570 |
|
||
|
Total liabilities |
|
93,348 |
|
84,918 |
|
||
|
|
|
|
|
|
|
||
|
Commitments and contingencies |
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
Stockholders equity: |
|
|
|
|
|
||
|
Preferred stock$.0001 par value; 10,000 shares authorized; no shares issued and outstanding |
|
|
|
|
|
||
|
Common stock$.0001 par value; 250,000 shares authorized; 53,738 and 52,508 shares issued and outstanding at July 2, 2005 and January 1, 2005, respectively |
|
5 |
|
5 |
|
||
|
Additional paid-in capital |
|
314,586 |
|
287,908 |
|
||
|
Deferred stock compensation |
|
(1,734 |
) |
(4,787 |
) |
||
|
Retained earnings |
|
149,345 |
|
116,358 |
|
||
|
Total stockholders equity |
|
462,202 |
|
399,484 |
|
||
|
Total liabilities and stockholders equity |
|
$ |
555,550 |
|
$ |
484,402 |
|
##